Publication: 33 questions about triglycerides and cardiovascular effects: expert answers
| dc.contributor.coauthor | Çetinkalp, Şevki | |
| dc.contributor.coauthor | Koylan, Nevrez | |
| dc.contributor.coauthor | Özer, Necla | |
| dc.contributor.coauthor | Onat, Altan | |
| dc.contributor.coauthor | Gökhan Özgen A. | |
| dc.contributor.coauthor | Lale Koldaş Z. | |
| dc.contributor.coauthor | Güven, Gülay Sain | |
| dc.contributor.coauthor | Özdoğan, Öner | |
| dc.contributor.coauthor | Karşıdağ, Kubilay | |
| dc.contributor.coauthor | Yiğit, Zerrin | |
| dc.contributor.coauthor | Kayıkçıoğlu, Meral | |
| dc.contributor.coauthor | Tokgözoğlu, Lale | |
| dc.contributor.coauthor | Can, Levent H. | |
| dc.contributor.coauthor | Tartan, Zeynep | |
| dc.contributor.coauthor | Kültürsay, Hakan | |
| dc.contributor.coauthor | Karpuz, Barış | |
| dc.contributor.coauthor | Kırılmaz, Bahadır | |
| dc.contributor.coauthor | Ersanlı, Murat | |
| dc.contributor.coauthor | Erbakan, Ayşe Naciye | |
| dc.contributor.coauthor | Oğuz, Aytekin | |
| dc.contributor.coauthor | Kayıkçıoğlu, Özcan R. | |
| dc.contributor.coauthor | Temizhan, Ahmet | |
| dc.contributor.coauthor | Sansoy, Vedat | |
| dc.contributor.coauthor | Ceyhan, Ceyhun | |
| dc.contributor.coauthor | Öngen, Zeki | |
| dc.contributor.coauthor | Bayram, Fahri | |
| dc.contributor.coauthor | Örem, Cihan | |
| dc.contributor.coauthor | Sönmez, Alper | |
| dc.contributor.coauthor | Beyaz, Şengül | |
| dc.contributor.coauthor | Ükinç, Kubilay | |
| dc.contributor.coauthor | Yürekli, Banu Şarer | |
| dc.contributor.coauthor | Çoker, Mahmut | |
| dc.contributor.coauthor | Canda, Ebru | |
| dc.contributor.coauthor | Şimşir, Ilgın Yıldırım | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.facultymember | Yes | |
| dc.contributor.kuauthor | Ural, Dilek | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2024-11-09T23:39:19Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | fenofibrat/simvastatin kombinasyonu ortalama 4.7 yıllık izlemde ölümcül olmayan ME, inme veya KV ölümleri hafifçe (%8; p=0.32) azalttı. Adl olan Tip 2DM hastalarında ölümcül olmayan ME, inme veya KV ölümler (%31; p=0.032) azaldı | tr |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | TR Dizin | |
| dc.description.openaccess | YES | |
| dc.description.peerreviewstatus | N/A | |
| dc.description.publisherscope | National | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.WoSQuartile | N/A | |
| dc.identifier.doi | 10.5543/tkda.2017.77459 | |
| dc.identifier.eissn | 1308-4488 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.endpage | 36 | |
| dc.identifier.issn | 1016-5169 | |
| dc.identifier.pubmed | 28446733 | |
| dc.identifier.scopus | 2-s2.0-85057380190 | |
| dc.identifier.startpage | 34 | |
| dc.identifier.uri | https://doi.org/10.5543/tkda.2017.77459 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/13085 | |
| dc.identifier.volume | 45 | |
| dc.identifier.wos | 000396440800002 | |
| dc.keywords | Fibrates | |
| dc.keywords | Cardiovascular events | |
| dc.keywords | Triglycerides | |
| dc.keywords | Dyslipidemia | |
| dc.keywords | Atherogenic dyslipidemia | |
| dc.keywords | Fenofibrate | |
| dc.keywords | Gemfibrozil | |
| dc.keywords | Type 2 diabetes mellitus | |
| dc.keywords | Lipid-lowering therapy | |
| dc.keywords | Coronary heart disease | |
| dc.language.iso | tur | |
| dc.publisher | KARE Publishing | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Archives of the Turkish Society of Cardiology | en |
| dc.relation.ispartof | Türk Kardiyoloji Derneği Arşivi | tr |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.subject | Cardiology | |
| dc.subject | Lipidology | |
| dc.subject | Cardiovascular disease | |
| dc.subject | Dyslipidemia | |
| dc.subject | Internal medicine | |
| dc.subject | Preventive cardiology | |
| dc.title | 33 questions about triglycerides and cardiovascular effects: expert answers | |
| dc.title.alternative | Soru 19– Fibratların kardiyovasküler olaylara etkisi var mı? | tr |
| dc.type | Other | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Ural, Dilek | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
